SCHEMBL30835992

SCHEMBL30835992

CC(C)(C)OC(=O)N1CCC(O)(C#Cc2ccc(C(F)(F)F)cc2)CC1

nearest known ligand 0.50

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.50
GPR119 Q8TDV5 4/20 0.46
TACR1 P25103 1/20 0.45
STS P08842 1/20 0.42
JAK2 O60674 1/20 0.41
JAK1 P23458 1/20 0.41
GPR183 P32249 2/20 0.40
RORC P51449 3/20 0.40
GRM5 P41594 1/20 0.40
HPGD P15428 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
SYK P43405 1/20 0.39
TGFBR1 P36897 1/20 0.39
HDAC1 Q13547 1/20 0.39
HDAC8 Q9BY41 1/20 0.39
HDAC6 Q9UBN7 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27402284 0.93 MAPT (0.46) MAPTGPR119TACR1STSJAK2
SCHEMBL30835859 0.89 MAPT (0.51) MAPTGPR119TACR1STSJAK2
SCHEMBL30835990 0.88 MAPT (0.50) MAPTGPR119TACR1STSJAK2
SCHEMBL5237507 0.88 GRM5 (0.49) GPR119JAK2JAK1GPR183RORC
SCHEMBL31556485 0.86 MAPT (0.48) MAPTGPR119TACR1STSJAK2
SCHEMBL5237125 0.85 GRM5 (0.47) GPR119TACR1STSGRM5HDAC1
SCHEMBL30836034 0.85 MAPT (0.47) MAPTGPR119TACR1STSJAK2
SCHEMBL30836009 0.84 MAPT (0.46) MAPTGPR119TACR1STSJAK2
SCHEMBL30836018 0.82 MAPT (0.44) MAPTGPR119TACR1STSJAK2
SCHEMBL19385687 0.80 MAPT (0.56) MAPTGPR119TACR1STSGPR183

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4587424-A1 YAP/TAZ-TEAD ONCOPROTEINS INHIBITORS Bridgene Biosciences, Inc. (US) 2025-07-23 EP disclosed
WO-2024059317-A1 YAP/TAZ-TEAD ONCOPROTEINS INHIBITORS BRIDGENE BIOSCIENCES, INC. (US) 2024-03-21 WO disclosed